Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CCAAGTCTGTACAGCATCTTGAGTCCCTTTTTACCGCTGTTACCAATTTTCTTTTGTCTTTGGGTATACATTTAAACCCTAACAAAACAAAGAGATGGGG| |TTACTCTCTAAATTTTATGGGTTATGTCATTGGATGTTATGGGTCCTTGCCACAAGAACACATCATACAAAAAATCAAAGAATGTTTTAGAAAACTTCCT
End
83878716/83651592 (Hg38)
Nearest miRNA
hsa-mir-1285-2/Upstream/3785009; hsa-mir-10b/Downstream/2132008;
Upstream sequence
GAACTCCCCAGTGGTAAATAAAATATATCATTCCCTTGGCCATCAAAATAGTTCTCATATAAAATTACAAGCATATATTCCAATAGGTGTTAGAAGGAAT
Downstream sequence
GGGCTTTCTATTAGAGAATAGTGGTTTTTAAAAGATAGACTGAGAACTTCTCAGATAAAAGCTAATTAGCCTTTGAAACATGCAGAACTGGGAATGGAAA
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.